HCPCS Codes for Medical care


  • G9813

    Patient did not die within 30 days of the procedure or during the index hospitalization
  • G9814

    Death occurring during the index acute care hospitalization
  • G9815

    Death did not occur during the index acute care hospitalization
  • G9816

    Death occurring after discharge from the hospital but within 30 days post procedure
  • G9817

    Death did not occur after discharge from the hospital within 30 days post procedure
  • G9818

    Documentation of sexual activity
  • G9819

    Patients who use hospice services any time during the measurement period
  • G9820

    Documentation of a chlamydia screening test with proper follow-up
  • G9821

    No documentation of a chlamydia screening test with proper follow-up
  • G9822

    Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)
  • G9823

    Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
  • G9824

    Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
  • G9825

    Her-2/neu negative or undocumented/unknown
  • G9826

    Patient transferred to practice after initiation of chemotherapy
  • G9827

    Her2-targeted therapies not administered during the initial course of treatment
  • G9828

    Her2-targeted therapies administered during the initial course of treatment
  • G9829

    Breast adjuvant chemotherapy administered
  • G9830

    Her-2/neu positive
  • G9831

    Ajcc stage at breast cancer diagnosis = ii or iii
  • G9832

    Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis = t1c
  • G9833

    Patient transfer to practice after initiation of chemotherapy
  • G9834

    Patient has metastatic disease at diagnosis
  • G9835

    Trastuzumab administered within 12 months of diagnosis
  • G9836

    Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)
  • G9837

    Trastuzumab not administered within 12 months of diagnosis
  • G9838

    Patient has metastatic disease at diagnosis
  • G9839

    Anti-egfr monoclonal antibody therapy
  • G9840

    Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab
  • G9841

    Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab
  • G9842

    Patient has metastatic disease at diagnosis
  • G9843

    Ras (kras or nras) gene mutation
  • G9844

    Patient did not receive anti-egfr monoclonal antibody therapy
  • G9845

    Patient received anti-egfr monoclonal antibody therapy
  • G9846

    Patients who died from cancer
  • G9847

    Patient received systemic cancer-directed therapy in the last 14 days of life
  • G9848

    Patient did not receive systemic cancer-directed therapy in the last 14 days of life
  • G9849

    Patients who died from cancer
  • G9850

    Patient had more than one emergency department visit in the last 30 days of life
  • G9851

    Patient had one or less emergency department visits in the last 30 days of life
  • G9852

    Patients who died from cancer
  • G9853

    Patient admitted to the icu in the last 30 days of life
  • G9854

    Patient was not admitted to the icu in the last 30 days of life
  • G9855

    Patients who died from cancer
  • G9856

    Patient was not admitted to hospice
  • G9857

    Patient admitted to hospice
  • G9858

    Patient enrolled in hospice
  • G9859

    Patients who died from cancer
  • G9860

    Patient spent less than three days in hospice care
  • G9861

    Patient spent greater than or equal to three days in hospice care
  • G9862

    Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons)